OUR SERVICES

Regulatory Affairs, Drug Development, Pharmacovigilance, Medical Writing, Pricing & Reimbursement, Market Access

MORE

ABOUT US

Partner of many pharmaceutical companies, managing hundreds of multi-task projects, on a worldwide-scale

MORE

EVENTS

Discover next events

MORE

BLOG

ALL POSTS
Oct, 13 2021

RPIS IN PIPS AND WAIVERS

The use of the research product identifier (RPI) is used to make EMA processes more efficient by creating a single identifier for ...

READ
Sep, 27 2021

PILOT PROGRAM EMA-FDA PARALLEL SCIENTIFIC ...

The European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) have established a pilot program, starting fro...

READ
Sep, 21 2021

COMMUNICATION AND ADVERTISING FOR OTC AND ...

Communication and advertising activities for OTC and SOP medicinal products addressed to the public are subject to specific rules,...

READ
RPN @regulatorypharmanet - JUN 4

CONTACT US

Our experts are available to help you with any question you might have








 
I accept THE PRIVACY POLICY